Achmea Investment Management B.V. Catalent, Inc. Transaction History

Achmea Investment Management B.V.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$32.18 - $46.57 $337,632 - $488,612	10,492 Added 169.28%	16,690 $750,000
Q3 2023 Nov 06, 2023	SELL	$44.2 - $50.2 $13,215 - $15,009	-299 Reduced 4.6%	6,198 $283,000
Q2 2023 Jul 24, 2023	BUY	$31.86 - $67.26 $197,468 - $416,877	6,198 Added 2072.91%	6,497 $281,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $683,254 - $903,050	-7,254 Reduced 96.04%	299 $33,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $32,641 - $42,562	299 Added 4.12%	7,553 $1.01 Million
Q3 2020 Nov 02, 2020	BUY	$72.74 - $92.5 $527,655 - $670,995	7,254 New	7,254 $622,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.